nelfinavir has been researched along with bevirimat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blair, WS; Butler, SL; Cao, J; Fok-Seang, J; Griffin, P; Isaacson, J; Jackson, RL; Murray, E; Patick, AK; Peng, Q; Perros, M; Pickford, C; Wu, H | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
2 other study(ies) available for nelfinavir and bevirimat
| Article | Year |
|---|---|
New small-molecule inhibitor class targeting human immunodeficiency virus type 1 virion maturation.
Topics: Anti-HIV Agents; Blotting, Western; Capsid Proteins; Cell Line; Cells, Cultured; HeLa Cells; HIV-1; Humans; Molecular Structure; Virion | 2009 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |